Objective: To analyse relationships between incidence of osteoporosis, age and clinical symptoms in older female patients in East China. Methods: Data from females aged !30 years, admitted to QiLu Hospital between January 1999 and December 2011 were retrospectively assessed for osteoporosis. Correlations between osteoporosis diagnosis, age and clinical symptoms were analysed. Factors associated with osteoporosis were assessed using logistic regression. Results: Out of 4212 patients enrolled, 1673 were assigned to the osteoporosis group and 2539 to the nonosteoporosis group. Neck, shoulder and arm pain negatively correlated with osteoporosis diagnosis. Lumbar and back pain had no correlation with osteoporosis diagnosis. In patients with osteoporosis there was no relationship between bone density and site of clinical symptoms. Bone density decreased, as age increased, in patients aged >50 years in the osteoporosis group. Conclusion: The present study revealed a relationship between epidemiological distribution of osteoporosis and associated factors in adult females suffering from pain or numbness, in East China.
Introduction
Osteoporosis is a disease characterized by degeneration of the bone microstructure and osteopenia, which leads to increasing bone brittleness and a tendency for fracture. Predominating in older adults, particularly postmenopausal women, 1 osteoporosis was diagnosed in approximately 83.9 million people in China during 1997. 2 Osteoporosis has become the fourth most common disease in the elderly 3 and due to the high degree of morbidity and mortality associated with osteoporotic fracture and related costs, there is a great necessity for developing preventative strategies. It has been reported that 0.6% of young women (20-49 years of age) have osteoporosis and 16% have osteopenia, whereas in Caucasian women !75 years of age, 38% have osteoporosis and 94% have osteopenia. 4 Early risk factor identification and intervention in high-risk groups may help to prevent the potential complications associated with osteoporotic fractures. Dual-energy X-ray absorptiometry (DEXA) is used to diagnose osteoporosis by measuring bone mineral density (BMD) at the hip and lumbar spine, 5 and is recommended by the World Health Organization (WHO) as the optimum technique for measuring BMD in diagnosing asymptomatic osteoporosis and estimating fracture risk. [6] [7] [8] Although BMD analysis is accurate in diagnosing osteoporosis, 9 in the authors' clinical experience few elderly women in China (particularly those in rural areas) are willing to attend hospital for a DEXA examination, due to cost and other personal reasons. Osteoporosis in not confirmed in these women until symptoms have become severe and the optimum time for therapy has been missed. In order to carry out early intervention, it is essential to understand the relationship between osteoporosis occurrence rate and clinical symptoms. There has been little research conducted in China regarding this issue. Thus, the present study investigated the relationship between osteoporosis and symptoms (such as pain at different sites, and numbness) in the older female population of East China.
Patients and methods

Study population and design
Adult women (!30 years), admitted to the QiLu Hospital of Shandong University, Ji'nan, China for pain or numbness in bones or joints from between 1998 and December 2011, were consecutively enrolled into this retrospective study. Inclusion criteria comprised a principal complaint of osteoarthralgia and at least one of the following clinical symptoms: (I) neck and shoulder pain or numbness; (II) lumbar and back pain or numbness; (III) knee pain or numbness. Exclusion criteria included: (I) diseases which may affect bone or calcium metabolism; (II) hepatic or renal inadequacy; (III) drug delivery that may interfere with bone or calcium metabolism (e.g. oestrogen, calcitionin, diphosphonate); (IV) inability to receive a bone density test. A retrospective case-control study design was used. BMD at the lumbar region (L2 -L5) was measured using the Stratos DEXA fullbody scanner (Diagnostic Medical Systems, Mauguio, France). Osteoporosis was diagnosed according to WHO criteria: normal, BMD value (T score) within þ1 to À1 SD of healthy young adult mean; osteopenia, BMD T score À1 to À2.5 SD below healthy young adult mean; osteoporosis, BMD T score >À2.5 SD of healthy young adult mean; severe osteoporosis, BMD T score >À2.5 SD and one or more osteoporotic fractures. Patients were assigned to two groups: osteoporosis group, BMD T score >À2.5 SD of healthy young adult mean; nonosteoporosis group, BMD T score À2.5 SD of healthy young adult mean (controls).
The study was approved by the Ethics Committee of QiLu Hospital and written informed consent was obtained from all patients prior to examination.
Data analyses
Incidence rates of neck, shoulder, lower back, upper back, leg or arm pain and numbness in one or more extremities in the osteoporosis group were compared with the nonosteoporosis controls. The relationship between clinical symptoms, including severity of symptoms, and BMD (of the lumbar vertebrae) was analysed in osteoporosis patients. Both groups were analysed for the relationship between age and BMD scores.
Statistical analyses
Statistical analyses were conducted using the SPSS Õ software package, version 15.0 (SPSS Inc., Chicago, IL, USA) for Windows Õ and data were presented as mean AE SD. Statistically significant between-group differences were assessed using an unpaired t-test for continuous data and 2 -test for categorical numeric data. A P-value 0.05 was considered statistically significant.
Correlations between clinical symptoms and diagnosis of osteoporosis were assessed using logistic regression. Analysis of variance was performed. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated and tested for statistical significance.
Results
Of 4212 cases included in the study, 1673 were assigned to the osteoporosis group and 2539 to the nonosteoporosis (control) group. The mean age AE SD of patients was 55.3 AE 3.3 years (range, 30-85 years).
In the osteoporosis group, the most common symptoms were lower back pain, upper back pain and leg pain, followed by shoulder pain, neck pain, arm pain, arm numbness and leg numbness. In the nonosteoporosis group, the most common symptom was lower back pain, followed by leg pain, shoulder pain, neck pain, upper back pain, arm pain and leg numbness. Statistically significant between-group differences were found in relation to neck pain, shoulder pain, leg numbness, arm pain and arm numbness (P < 0.05, Table 1 ). In the osteoporosis group, 35 patients had no clinical symptoms. There was no statistically significant difference in lumbar vertebrae BMD results between the osteoporosis patients with clinical symptoms, compared with those without clinical symptoms (95% CI À0.05301,À0.20221, Table 2 ).
In the osteoporosis group, no statistically significant differences in mean BMD were found when data were divided, based on the number of body sites with pain symptoms. There were no statistically significant differences in mean BMD when data were divided, depending on the number of pain sites requiring analgesia ( Table 3 ).
The occurrence of osteoporosis correlated negatively with symptoms of neck, shoulder or arm pain, and leg numbness (P < 0.05). There was no statistically significant correlation between the occurrence of osteoporosis and lower back, upper back, or leg pain and arm numbness ( Table 4 ).
In the osteoporosis group, the highest percentage of female patients with osteoporosis was observed at 60-69 years of age. In patients aged >50 years, mean BMD decreased as age increased. In the nonosteoporosis group, mean BMD decreased with age up to 60-69 years of age but increased slightly in the >70 years age group (Table 5 ). 
Discussion
Clinical data indicate that osteoporosis is the main cause of pathological fractures in older adults, leading to disability and death. 10 Morbidity, distribution and other factors associated with osteoporosis vary by country and region. [11] [12] [13] In developing countries, the ability to understand risk factors, at-risk populations and identify the presence of osteoporosis prior to bone fracture, would aid in osteoporosis prevention and treatment, potentially saving considerable costs to health systems.
Epidemiological studies into osteoporosistraditionally include the analysis of bone fracture incidence and prevalence, and the use of clinical methods to measure bone mass or BMD. BMD is an important determinant of fracture risk, particularly in women of aged !65 years. 14, 15 In the USA, $20% of Caucasian women aged !50 years have osteoporosis, defined as a femoral BMD score >2.5 SD below the mean of young, healthy Caucasian women. 16, 17 Another 35-50% of these women have low bone mass, defined as BMD score 1 -2.5 SD below the mean of young, healthy Caucasian women. In general, lower BMD scores indicate more severe osteoporosis and higher risk of fracture. It has been reported that a decrease of 1 SD in BMD score represents a 10-12% decrease in BMD and an increase in fracture risk from 1.5 to 2.6. 18, 19 BMD and fracture risk are most closely related when bone density is used to predict fracture risk at that same site. Other research demonstrated that risks for spine and hip fracture increased 2.3-fold and 2.6-fold, respectively, for each decrease of 1 SD in age-adjusted BMD scores measured at the spine and hip. 20 The importance of preventing osteoporosis and reducing osteoporosis related complications was highlighted in a European vertebral osteoporosis study of 15 570 men and women aged 50-79 years, where osteoporosis was found to affect 3-6% of women aged >50 years, and a UK study in which lifetime risk of hip fracture for 50-year-olds was found to be 11.4% for women and 3.1% for men. [21] [22] [23] [24] The occurrence of osteoporosis is influenced by many factors, especially decreasing rates of peak bone mass and increasing osteopenia following the menopause. Lack of oestrogen following menopause and ageing is thought to be the main cause of osteoporosis, 25 with most cases of osteoporosis occurring in postmenopausal women, and incidence increasing with age. Epidemiological studies have indicated that the incidence of osteoporosis in females aged 50-59 years is >50% due to changes in endocrine metabolism. 26 Oestrogen levels decrease significantly following the menopause, especially in the first 5-10 years. 27 Furthermore, women who experience increased bone loss within 3 years of the menopause have been shown to be twice as likely to have vertebral and peripheral fractures as their peers who exhibit a normal or slower bone-losing process. 28 Osteoporosis rates vary with ethnicity, with the highest rates in people of Caucasian ethnicity and the lowest rates in people of African-American ethnicity. 29 Knowledge of the relationship between osteoporosis and clinical symptoms in the Chinese population is important in understanding the racial characteristics of osteoporosis in East Asia, and in generating new ideas for research into osteoporosis.
Research has shown that 67% of osteoporosis patients have localized lower back pain, 9% have lower back pain with extremity radiating pain, 10% have lower back with girdle pain, 4% have lower back pain with numbness, and 10% have lower back pain, limb numbness and numbness/ weakness in the lumbar region. 17 The present study showed that shoulder pain and arm pain could not support the diagnosis of osteoporosis individually. Lower back pain, leg pain and numbness had no relative specificity to the diagnosis of osteoporosis: differential diagnosis is needed to distinguish osteoporosis from a slipped disc or a muscle strain. In addition, in our data, symptom severity had no correlation with BMD and number of clinical symptoms did not indicate osteoporosis severity. The present study indicated that the incidence of osteoporosis increased in women after the age of 50, reaching its peak in those aged 60-69 years. Therefore, prevention strategies should be aimed at patients aged between 50 and 69 years of age, in particular.
The present study includes data on the relationship between epidemiological distribution of osteoporosis and associated factors, in older Chinese females with skeletal pain or numbness, in the Shandong Province. Further research should include a group of normal age-matched control subjects in order to relate the study outcomes to the wider Chinese population. Since this study included data collected over a 14-year period, analysis of the incidence of osteoporosis by year may reveal useful information on trends. The current research indicated a relationship between clinical symptoms of pain and numbness and osteoporosis, and may assist in the diagnosis of osteoporosis in the clinic.
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